Ceyhan M - Search Results

1

Immunogenicity of the 9-Valent HPV Vaccine Using 2-Dose Regimens in Girls and Boys vs a 3-Dose Regimen in Women.

Iversen OE, Miranda MJ, Ulied A, Soerdal T, Lazarus E, Chokephaibulkit K, Block SL, Skrivanek A, Nur Azurah AG, Fong SM, Dvorak V, Kim KH, Cestero RM, Berkovitch M, Ceyhan M, Ellison MC, Ritter MA, Yuan SS, DiNubile MJ, Saah AJ, Luxembourg A. Iversen OE, et al. Among authors: ceyhan m. JAMA. 2016 Dec 13;316(22):2411-2421. doi: 10.1001/jama.2016.17615. JAMA. 2016. PMID: 27893068 Clinical Trial.

2

Serological evaluation of 52 children immunized with the combined measles, mumps and rubella vaccine.

Topal B, Kanra G, Ceyhan M. Topal B, et al. Among authors: ceyhan m. Turk J Pediatr. 1991 Jan-Mar;33(1):13-8. Turk J Pediatr. 1991. PMID: 1844171

3

Immunogenicity study of a combined diphtheria, tetanus, acellular pertussis, inactivated poliomyelitis vaccine used to reconstitute a freeze-dried Haemophilus influenzae type b vaccine (DTaP-IPV//PRP-T) administered simultaneously with a hepatitis B vaccine at two, three and four months of life.

Kanra G, Silier T, Yurdakök K, Yavuz T, Baskan S, Ulukol B, Ceyhan M, Ozmert E, Türkay F, Pehlivan T. Kanra G, et al. Among authors: ceyhan m. Vaccine. 1999 Dec 10;18(9-10):947-54. doi: 10.1016/s0264-410x(99)00331-x. Vaccine. 1999. PMID: 10580209 Clinical Trial.

4

Safety, tolerability and immunogenicity of a Haemophilus influenzae type b vaccine containing aluminum phosphate adjuvant administered at 2, 3 and 4 months of age.

Kanra G, Viviani S, Yurdakök K, Ozmert E, Yalçin S, Baldini A, Mutlu B, Kara A, Ceyhan M, Podda A. Kanra G, et al. Among authors: ceyhan m. Turk J Pediatr. 1999 Oct-Dec;41(4):421-7. Turk J Pediatr. 1999. PMID: 10770109 Clinical Trial.

5

Clinical trial to evaluate immunogenicity and safety of inactivated hepatitis A vaccination starting at 2-month-old children.

Kanra G, Yalçin SS, Ceyhan M, Yurdakök K. Kanra G, et al. Among authors: ceyhan m. Turk J Pediatr. 2000 Apr-Jun;42(2):105-8. Turk J Pediatr. 2000. PMID: 10936974 Clinical Trial.

6

Safety and immunogenicity of live attenuated varicella vaccine in 9-month-old children.

Kanra G, Ceyhan M, Ozmert E. Kanra G, et al. Among authors: ceyhan m. Pediatr Int. 2000 Dec;42(6):674-7. doi: 10.1046/j.1442-200x.2000.01300.x. Pediatr Int. 2000. PMID: 11192526 Clinical Trial.

7

Reactogenicity and immunogenicity of a new measles-mumps-rubella vaccine containing RIT 4385 mumps virus strain in healthy Turkish children.

Kanra G, Ceyhan M, Ozmert E. Kanra G, et al. Among authors: ceyhan m. Turk J Pediatr. 2000 Oct-Dec;42(4):275-7. Turk J Pediatr. 2000. PMID: 11196741 Clinical Trial.

8

Two booster dose hepatitis B virus vaccination in patients with leukemia.

Yetgin S, Tunç B, Koç A, Toksoy HB, Ceyhan M, Kanra G. Yetgin S, et al. Among authors: ceyhan m. Leuk Res. 2001 Aug;25(8):647-9. doi: 10.1016/s0145-2126(00)00101-6. Leuk Res. 2001. PMID: 11397468

9

Immunogenicity and efficacy of one dose measles-mumps-rubella (MMR) vaccine at twelve months of age as compared to monovalent measles vaccination at nine months followed by MMR revaccination at fifteen months of age.

Ceyhan M, Kanra G, Erdem G, Kanra B. Ceyhan M, et al. Vaccine. 2001 Aug 14;19(31):4473-8. doi: 10.1016/s0264-410x(01)00207-9. Vaccine. 2001. PMID: 11483273 Clinical Trial.

10

The prevalence of different HPV types in Turkish women with a normal Pap smear.

Demir ET, Ceyhan M, Simsek M, Gunduz T, Arlier S, Aytac R, Aycan AE, Gurbuz V. Demir ET, et al. Among authors: ceyhan m. J Med Virol. 2012 Aug;84(8):1242-7. doi: 10.1002/jmv.23333. J Med Virol. 2012. PMID: 22711352

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

322 results

Search Page